Home ETF List About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab
Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) EW holdings

DateNumber of EW Shares HeldBase Market Value of EW SharesLocal Market Value of EW SharesChange in EW Shares HeldChange in EW Base ValueCurrent Price per EW Share HeldPrevious Price per EW Share Held
2025-10-01 (Wednesday)93,081USD 7,103,011USD 7,103,011
2025-09-30 (Tuesday)92,635USD 7,204,224EW holding increased by 53728USD 7,204,2240USD 53,728 USD 77.77 USD 77.19
2025-09-29 (Monday)92,635EW holding increased by 24USD 7,150,496EW holding increased by 88907USD 7,150,49624USD 88,907 USD 77.19 USD 76.25
2025-09-26 (Friday)92,611EW holding decreased by -1238USD 7,061,589EW holding decreased by -2425USD 7,061,589-1,238USD -2,425 USD 76.25 USD 75.27
2025-09-25 (Thursday)93,849EW holding increased by 655USD 7,064,014EW holding increased by 106150USD 7,064,014655USD 106,150 USD 75.27 USD 74.66
2025-09-24 (Wednesday)93,194USD 6,957,864USD 6,957,864
2025-09-18 (Thursday)88,596EW holding increased by 336USD 6,604,832EW holding decreased by -32320USD 6,604,832336USD -32,320 USD 74.55 USD 75.2
2025-09-17 (Wednesday)88,260EW holding increased by 559USD 6,637,152EW holding increased by 51684USD 6,637,152559USD 51,684 USD 75.2 USD 75.09
2025-09-16 (Tuesday)87,701USD 6,585,468EW holding decreased by -84193USD 6,585,4680USD -84,193 USD 75.09 USD 76.05
2025-09-15 (Monday)87,701EW holding increased by 271USD 6,669,661EW holding decreased by -112284USD 6,669,661271USD -112,284 USD 76.05 USD 77.57
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BHZPJ890

Show aggregate share trades of EW

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-29BUY24 77.190* 72.75
2025-09-26SELL-1,238 76.250* 72.73 Profit of 90,045 on sale
2025-09-25BUY655 75.270* 72.72
2025-09-18BUY336 74.550* 72.71
2025-09-17BUY559 75.200* 72.70
2025-09-15BUY271 76.050* 72.66
2025-09-12BUY204 77.570* 72.64
2025-09-11SELL-709 78.010* 72.61 Profit of 51,479 on sale
2025-09-10BUY120 78.280* 72.58
2025-09-09BUY156 79.800* 72.54
2025-08-27SELL-438,026 80.900* 72.44 Profit of 31,729,527 on sale
2025-08-21BUY136 81.160* 72.33
2025-08-19BUY420 78.930* 72.24
2025-07-21BUY71 76.560* 72.22
2025-07-18BUY3,216 76.490* 72.19
2025-07-17BUY425 76.180* 72.17
2025-07-16BUY6,244 76.140* 72.14
2025-07-15BUY3,850 76.810* 72.11
2025-07-03SELL-544 76.790* 72.06 Profit of 39,200 on sale
2025-07-02SELL-4,404 77.020* 72.03 Profit of 317,209 on sale
2025-06-30SELL-95 78.210* 71.99 Profit of 6,839 on sale
2025-06-27BUY284 78.210* 71.95
2025-06-26BUY142 77.150* 71.92
2025-06-25BUY284 76.970* 71.89
2025-06-24SELL-213 75.850* 71.86 Profit of 15,306 on sale
2025-06-17SELL-282 73.270* 71.79 Profit of 20,244 on sale
2025-06-13SELL-126 75.150* 71.75 Profit of 9,040 on sale
2025-06-12BUY204 75.890* 71.72
2025-06-06SELL-980 77.520* 71.59 Profit of 70,162 on sale
2025-06-05SELL-1,540 77.770* 71.55 Profit of 110,189 on sale
2025-06-04SELL-1,972 77.850* 71.51 Profit of 141,013 on sale
2025-06-03BUY408 77.720* 71.46
2025-06-02SELL-120 78.100* 71.42 Profit of 8,570 on sale
2025-05-30SELL-377,266 78.220* 71.37 Profit of 26,925,127 on sale
2025-05-29SELL-735 77.730* 71.32 Profit of 52,423 on sale
2025-05-28SELL-484 76.660* 71.29 Profit of 34,502 on sale
2025-05-23SELL-2,148 74.990* 71.19 Profit of 152,926 on sale
2025-05-22BUY118 74.790* 71.17
2025-05-21SELL-605 76.100* 71.13 Profit of 43,034 on sale
2025-05-20BUY2,596 77.830* 71.08
2025-05-16SELL-1,089 78.000* 70.97 Profit of 77,291 on sale
2025-05-15BUY127 76.880* 70.93
2025-05-14BUY2,136 76.750* 70.88
2025-05-13BUY7,773 75.500* 70.85
2025-05-12BUY6,254 74.800* 70.82
2025-05-09BUY2,006 73.680* 70.79
2025-05-08SELL-1,936 74.630* 70.76 Profit of 136,998 on sale
2025-05-07BUY5,546 75.040* 70.73
2025-05-06BUY1,298 74.920* 70.70
2025-05-02SELL-221 75.650* 70.62 Profit of 15,606 on sale
2025-05-01SELL-118 75.180* 70.58 Profit of 8,328 on sale
2025-04-29BUY3 76.280* 70.49
2025-04-28SELL-16,333 75.540* 70.45 Profit of 1,150,603 on sale
2025-04-25SELL-236 76.040* 70.40 Profit of 16,614 on sale
2025-04-24SELL-3,658 75.130* 70.36 Profit of 257,366 on sale
2025-04-23SELL-1,298 70.460* 70.36 Profit of 91,322 on sale
2025-04-22SELL-847 70.600* 70.35 Profit of 59,590 on sale
2025-04-16SELL-4,602 71.200* 70.34 Profit of 323,683 on sale
2025-04-11BUY2,305 69.400* 70.34
2025-04-10BUY726 68.260* 70.36
2025-04-09BUY1,195 69.900* 70.37
2025-04-08SELL-3,386 67.070* 70.40 Profit of 238,377 on sale
2025-04-07BUY2,284 69.000* 70.41
2025-04-04BUY5,026 69.360* 70.43
2025-04-02BUY2,030 72.050* 70.41
2025-04-01BUY968 71.870* 70.39
2025-03-31SELL-5,203 72.480* 70.37 Profit of 366,149 on sale
2025-03-28SELL-488 70.910* 70.37 Profit of 34,339 on sale
2025-03-26BUY122 71.090* 70.35
2025-03-25BUY366 71.240* 70.34
2025-03-24BUY732 71.350* 70.33
2025-03-21BUY18,788 70.460* 70.33
2025-03-20BUY244 70.950* 70.32
2025-03-19SELL-3,422 70.900* 70.32 Profit of 240,621 on sale
2025-03-17SELL-244 70.630* 70.31 Profit of 17,156 on sale
2025-03-14SELL-488 69.290* 70.32 Profit of 34,318 on sale
2025-03-13SELL-118 67.950* 70.35 Profit of 8,301 on sale
2025-03-12SELL-724 68.510* 70.37 Profit of 50,950 on sale
2025-03-11BUY122 68.390* 70.40
2025-03-06BUY7,316 71.800* 70.40
2025-03-05SELL-602 72.850* 70.37 Profit of 42,364 on sale
2025-03-03BUY366 71.390* 70.35
2025-02-28SELL-175,742 71.620* 70.33 Profit of 12,359,980 on sale
2025-02-27SELL-2,860 71.400* 70.32 Profit of 201,104 on sale
2025-02-26SELL-36,607 71.960* 70.29 Profit of 2,573,262 on sale
2025-02-25SELL-2,499 71.450* 70.28 Profit of 175,626 on sale
2025-02-24BUY3,575 72.760* 70.24
2025-02-21BUY1,867 73.300* 70.20
2025-02-20BUY345 74.710* 70.14
2025-02-19BUY294 74.670* 70.07
2025-02-18SELL-1,597 75.670* 69.99 Profit of 111,779 on sale
2025-02-14BUY441 76.190* 69.81
2025-02-13SELL-294 76.000* 69.71 Profit of 20,496 on sale
2025-02-12SELL-5,586 75.820* 69.62 Profit of 388,898 on sale
2025-02-10SELL-44 71.100* 69.58 Profit of 3,061 on sale
2025-02-06BUY787 70.990* 69.54
2025-02-05SELL-2,205 72.100* 69.50 Profit of 153,242 on sale
2025-02-03BUY261 71.380* 69.43
2025-01-30SELL-3,003 73.220* 69.31 Profit of 208,144 on sale
2025-01-29SELL-16 71.130* 69.28 Profit of 1,108 on sale
2025-01-28SELL-1,947 72.560* 69.22 Profit of 134,768 on sale
2025-01-27BUY882 69.200* 69.22
2025-01-24BUY1,573 68.990* 69.22
2025-01-23BUY1,573 68.930* 69.23
2024-12-09BUY292 70.900* 69.11
2024-12-06BUY4,526 71.530* 69.06
2024-12-04BUY3,358 74.200* 68.87
2024-12-03BUY1,952 70.200* 68.84
2024-12-02BUY4,380 70.530* 68.81
2024-11-29BUY438 71.350* 68.75
2024-11-27BUY146 72.070* 68.59
2024-11-26SELL-5,024 71.550* 68.43 Profit of 343,809 on sale
2024-11-26SELL-5,024 71.550* 68.43 Profit of 343,809 on sale
2024-11-25BUY90,542 71.270* 68.28
2024-11-25BUY90,542 71.270* 68.28
2024-11-22SELL-240 70.480* 68.22 Profit of 16,373 on sale
2024-11-21BUY5,556 70.380* 68.16
2024-11-19SELL-1,190 70.200* 68.05 Profit of 80,983 on sale
2024-11-18BUY2,632 69.890* 68.00
2024-11-12BUY132 65.810* 68.07
2024-11-08BUY391 66.230* 68.25
2024-11-08BUY391 66.230* 68.25
2024-11-07BUY10,010 65.840* 68.43
2024-11-07BUY10,010 65.840* 68.43
2024-11-06BUY264 65.750* 68.66
2024-11-06BUY264 65.750* 68.66
2024-11-05SELL-670 66.690* 68.83 Profit of 46,119 on sale
2024-11-05SELL-670 66.690* 68.83 Profit of 46,119 on sale
2024-11-04SELL-4,680 66.470* 69.07 Profit of 323,248 on sale
2024-11-04SELL-4,680 66.470* 69.07 Profit of 323,248 on sale
2024-11-01SELL-1,320 67.540* 69.24 Profit of 91,397 on sale
2024-11-01SELL-1,320 67.540* 69.24 Profit of 91,397 on sale
2024-10-31BUY757 67.010* 69.52
2024-10-31BUY757 67.010* 69.52
2024-10-30SELL-5,004 68.630* 69.65 Profit of 348,507 on sale
2024-10-30SELL-5,004 68.630* 69.65 Profit of 348,507 on sale
2024-10-29SELL-4,680 69.370* 69.69 Profit of 326,157 on sale
2024-10-29SELL-4,680 69.370* 69.69 Profit of 326,157 on sale
2024-10-28BUY390 68.520* 69.93
2024-10-28BUY390 68.520* 69.93
2024-10-25BUY8,448 69.380* 70.06
2024-10-25BUY8,448 69.380* 70.06
2024-10-24BUY1,028 70.350* 69.97
2024-10-24BUY1,028 70.350* 69.97
2024-10-23SELL-216 70.610* 69.65 Profit of 15,043 on sale
2024-10-23SELL-216 70.610* 69.65 Profit of 15,043 on sale
2024-10-22BUY910 69.240* 70.05
2024-10-22BUY910 69.240* 70.05
2024-10-21SELL-9,100 70.050* 0.00
2024-10-21SELL-9,100 70.050* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19406,40201,881,72721.6%
2025-09-18684,5201,1773,487,98119.6%
2025-09-17484,3222101,603,06530.2%
2025-09-16811,9538562,055,93739.5%
2025-09-15611,0121041,391,88243.9%
2025-09-12982,9281,1002,234,22744.0%
2025-09-11514,2348281,919,00926.8%
2025-09-10669,7051491,567,94142.7%
2025-09-09441,4930925,37547.7%
2025-09-08632,5876721,251,93950.5%
2025-09-05334,037300934,00635.8%
2025-09-04380,3180871,93143.6%
2025-09-03701,9434591,170,96659.9%
2025-09-02397,396531,208,87232.9%
2025-08-29397,628800844,31847.1%
2025-08-28604,08741,056,65357.2%
2025-08-27493,608822875,88656.4%
2025-08-26480,2680868,21355.3%
2025-08-25796,55601,181,25867.4%
2025-08-22552,73911,011,67854.6%
2025-08-21873,0447981,597,74254.6%
2025-08-20847,84738,6991,560,10554.3%
2025-08-19613,349331,256,57748.8%
2025-08-18668,7194391,642,75940.7%
2025-08-15369,455513826,72344.7%
2025-08-14514,2026,112864,59359.5%
2025-08-13567,8572991,347,26442.1%
2025-08-12547,77312,3161,428,27738.4%
2025-08-11487,82301,152,63042.3%
2025-08-08661,697201,224,45854.0%
2025-08-07669,9319821,297,46951.6%
2025-08-06880,0284131,551,65956.7%
2025-08-05661,93381,592,64941.6%
2025-08-04572,1652681,310,04443.7%
2025-08-01678,0285,6001,308,86351.8%
2025-07-31831,4012491,817,97545.7%
2025-07-301,305,0166932,481,80852.6%
2025-07-291,129,154582,399,22347.1%
2025-07-28684,1012,1112,276,89230.0%
2025-07-251,669,7529206,616,25925.2%
2025-07-24455,59302,607,89817.5%
2025-07-23444,64501,978,11022.5%
2025-07-22447,8835112,702,92516.6%
2025-07-21568,293271,249,72745.5%
2025-07-18590,448592,118,40227.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.